Recurrence and survival after total mesorectal excision for rectal cancer

Area of Science:

• Surgical Oncology
• Gastrointestinal Surgery

Background:

• Rectal cancer treatment often involves radical surgery.
• Abdominoperineal excision with permanent colostomy has historically been common.
• Minimally invasive techniques aim to improve patient outcomes and quality of life.

Purpose of the Study:

• To evaluate the safety and efficacy of lower anterior resections for rectal cancer.
• To assess the impact of limited mural clearance on oncological outcomes.
• To determine the feasibility of preserving anal sphincters in rectal cancer surgery.

Main Methods:

• Retrospective analysis of 115 patients undergoing curative resection for rectal carcinoma.
• Focus on lower anterior resections with varying mural resection margins.
• Assessment of pelvic and staple-line recurrence rates, and survival data.

Main Results:

• 11% rate of abdominoperineal excision with permanent colostomy.
• No staple-line recurrences observed in patients with curative intent surgery.
• 5-year corrected cumulative survival of 87%; tumor-free survival by Dukes stage: A 94%, B 87%, C 58%.

Conclusions:

• Limited mural clearance is often safe in rectal cancer surgery when the mesorectum is excised intact.
• Lower anterior resection can preserve anal sphincters without compromising survival or increasing recurrence.
• Complete mesorectal excision remains a priority for achieving optimal oncological control.